HDLs have consistently drawn attention in targeting HCC due to the increased expression of HDL receptors such as SR-B1 in order to satisfy the tumors’ insistent appetite for cholesterol for cell proliferation. The gene discussed is SCARB1; the disease is hepatocellular carcinoma.